HCA Healthcare (HCA) Cash & Equivalents (2010 - 2026)

HCA Healthcare has disclosed Cash & Equivalents across 17 years of filings, most recently posting $940.0 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 11.32% year-over-year to $940.0 million; the TTM figure through Mar 2026 stood at $940.0 million (down 11.32% YoY), while the FY2025 annual figure was $1.0 billion, down 46.2% from the prior year.
• Cash & Equivalents slipped to $940.0 million in Q1 2026, from $1.0 billion in the prior quarter.
• Over the last five years, Cash & Equivalents for HCA reached as high as $2.9 billion in Q3 2024 and fell as low as $493.0 million in Q2 2022.
• The 5-year median for Cash & Equivalents is $939.0 million (2025), against an average of $1.1 billion.
• Annual changes were most pronounced in 2024 — Cash & Equivalents soared 224.13% — and 2025, when it slumped 65.48%.
• A 5-year view of Cash & Equivalents shows it stood at $908.0 million in 2022, then advanced by 2.97% to $935.0 million in 2023, then jumped by 106.74% to $1.9 billion in 2024, then tumbled by 46.2% to $1.0 billion in 2025, then fell by 9.62% to $940.0 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $940.0 million, $1.0 billion, and $997.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.